# Springhill Fund Asset Management (HK) Co Ltd

> Institutional holdings reported to the SEC as of Q1 2025 on Form 13F. CIK 1911270. Source: https://holderbook.com/funds/1911270-springhill-fund-asset-management-hk-co-ltd/

- Reported value: $20.9M
- Positions: 19
- Weight of the ten largest: 82.9%
- Filed: 2025-05-14

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| VERONA PHARMA PLC | [VRNA](https://holderbook.com/stocks/VRNA/) | $4.0M | 63,499 | 19.3% | 2 |
| SUMMIT THERAPEUTICS INC | [SMMT](https://holderbook.com/stocks/SMMT/) | $2.4M | 124,307 | 11.5% | 1 |
| JANUX THERAPEUTICS INC | [JANX](https://holderbook.com/stocks/JANX/) | $2.1M | 78,500 | 10.2% | 2 |
| REGENERON PHARMACEUTICALS | [REGN](https://holderbook.com/stocks/REGN/) | $1.6M | 2,600 | 7.9% | 1 |
| NEUROCRINE BIOSCIENCES INC | [NBIX](https://holderbook.com/stocks/NBIX/) | $1.5M | 13,612 | 7.2% | 1 |
| INSMED INC | [INSM](https://holderbook.com/stocks/INSM/) | $1.5M | 19,192 | 7.0% | 2 |
| SOLENO THERAPEUTICS INC | [SLNO](https://holderbook.com/stocks/SLNO/) | $1.4M | 19,858 | 6.8% | 2 |
| JAZZ PHARMACEUTICALS PLC | [JAZZ](https://holderbook.com/stocks/JAZZ/) | $1.2M | 9,853 | 5.9% | 1 |
| AKERO THERAPEUTICS INC | [AKRO](https://holderbook.com/stocks/AKRO/) | $806.6K | 19,925 | 3.9% | 2 |
| ARGENX SE | [ARGX](https://holderbook.com/stocks/ARGX/) | $678.3K | 1,146 | 3.3% | 1 |
| ELI LILLY & CO | [LLY](https://holderbook.com/stocks/LLY/) | $673.9K | 816 | 3.2% | 1 |
| PROTAGONIST THERAPEUTICS INC | [PTGX](https://holderbook.com/stocks/PTGX/) | $621.9K | 12,859 | 3.0% | 1 |
| TG THERAPEUTICS INC | [TGTX](https://holderbook.com/stocks/TGTX/) | $532.3K | 13,500 | 2.6% | 1 |
| TARSUS PHARMACEUTICALS INC | [TARS](https://holderbook.com/stocks/TARS/) | $363.5K | 7,076 | 1.7% | 1 |
| ASCENDIS PHARMA A/S | [ASND](https://holderbook.com/stocks/ASND/) | $338.7K | 2,173 | 1.6% | 1 |
| RHYTHM PHARMACEUTICALS INC | [RYTM](https://holderbook.com/stocks/RYTM/) | $332.5K | 6,277 | 1.6% | 1 |
| BIONTECH SE | [BNTX](https://holderbook.com/stocks/BNTX/) | $273.2K | 3,000 | 1.3% | 1 |
| SPRINGWORKS THERAPEUTICS INC | [SWTX](https://holderbook.com/stocks/SWTX/) | $260.2K | 5,897 | 1.2% | 1 |
| COGENT BIOSCIENCES INC | [COGT](https://holderbook.com/stocks/COGT/) | $176.7K | 29,491 | 0.8% | 2 |

## What the disclosed book did

Not the fund's return. This is the change in value of the positions disclosed on Form 13F, had they been left untouched, against SPY over the same quarter ends.

| Quarter | Book | Market | Difference | Priced |
|---|---|---|---|---|
| Q1 2025 | -6.5% | -4.6% | -1.9% | 100% |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q1 2025 | $20.9M | 19 |
| Q4 2024 | $61.6M | 17 |